What's new in hepatitis C virus infections in children?

Area of Science:

• Pediatric Infectious Diseases
• Hepatology
• Virology

Background:

• Hepatitis C virus (HCV) infections are infrequent in pediatric populations, potentially due to limited screening and asymptomatic disease progression.
• Mother-to-infant transmission represents the primary route of HCV acquisition in children within developed nations.
• Current prevention strategies for perinatal HCV infection are limited, highlighting the need for improved diagnostic and therapeutic approaches.

Purpose of the Study:

• To emphasize the importance of implementing routine HCV screening in pregnant women to mitigate vertical transmission.
• To explore genetic markers, such as IL-28B single nucleotide polymorphisms, and vitamin D levels as predictors of treatment response in children.
• To advocate for the development of non-invasive methods for assessing liver fibrosis in pediatric HCV cases.

Main Methods:

• Review of current literature on pediatric HCV epidemiology and transmission.
• Discussion of potential risk factors and preventive measures, including elective cesarean section.
• Exploration of genetic and biochemical markers for predicting treatment outcomes and disease progression.

Main Results:

• Vertical transmission risk of HCV is approximately 5%, with a range of 3%-10%.
• IL-28B polymorphisms and vitamin D levels are identified as potential predictors for spontaneous clearance and treatment response in children.
• Differences in liver injury mechanisms between pediatric and adult patients necessitate tailored interventions.

Conclusions:

• Routine screening of pregnant women for HCV is essential for early detection and prevention of perinatal transmission.
• Genetic and biochemical markers show promise in personalizing HCV treatment strategies for children.
• Further research into non-invasive fibrosis assessment and understanding pediatric-specific liver injury mechanisms is vital for reducing long-term liver disease progression.